Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Clinical Laserthermia Systems

1.59 SEK+0.51 %19/11 15:53
Less than 1K followers

CLS B

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
+0.51 %
-11.27 %
-12.25 %
-62.20 %
-76.65 %
-77.47 %
-93.43 %
-99.36 %
-99.35 %

Clinical Laserthermia Systems operates in the medical technology sector. The company's vision is to develop and streamline the treatment of solid cancer tumors, where the company is a seller of sterile patient kits. The products are used in various cancer treatments such as in the treatment of malignant melanoma, as well as cancer of the lungs, liver and pancreas. The company was founded in 2006 and has its headquarters in Lund.

Read more
Market cap
77.14M SEK
Turnover
83.44K SEK
Revenue
17.49M
EBIT %
-164.75 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
19/2
2027

Annual report '26

7/5
2027

Interim report Q1'27

20/8
2027

Interim report Q2'27

Regulatory press release2026-11-19 08:30

CLS och advanced fiber tools GmbH ingår strategiskt partnerskap för att söka bredare kommersiella möjligheter inom medicinsk laserterapi

Clinical Laserthermia Systems
Regulatory press release2026-11-19 08:30

CLS and advanced fiber tools enter strategic partnership to pursue broader commercial opportunities in medical laser therapy

Clinical Laserthermia Systems
Press release2026-11-16 17:35

Redeye: CLS (Q3 Review): Delivery timing weighs on Q3, but set up for a stronger Q4

Clinical Laserthermia Systems

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
Followings and notifications on followed companies
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release2026-11-13 08:50

CLS publicerar delårsrapport januari - september 2026

Clinical Laserthermia Systems
Regulatory press release2026-11-13 08:50

CLS Publishes Interim Report January - September 2026

Clinical Laserthermia Systems
Regulatory press release2026-11-12 15:05

LITT Behandling av Glioblastom med CLS Icke-kylda Lasersystem visar Lovande Resultat

Clinical Laserthermia Systems
Regulatory press release2026-11-12 15:05

LITT Treatment of Glioblastoma with CLS Non-Cooled Laser System shows Promising Results

Clinical Laserthermia Systems
Press release2026-10-30 14:14

Redeye: CLS: Industry partner in NCI-funded programme for spinal metastases

Clinical Laserthermia Systems
Regulatory press release2026-10-29 08:30

CLS utsett som industripartner i ett femårigt forskningsprogram finansierat av NIH i USA för att vidareutveckla MR-ledd laserterapi för spinala metastaser

Clinical Laserthermia Systems
Regulatory press release2026-10-29 08:30

CLS awarded as Industry Partner in NIH-Funded Five-Year Research Program in U.S to Advance MR-Guided Laser Therapy for Spinal Metastases

Clinical Laserthermia Systems
Regulatory press release2026-09-07 14:30

CLS: Clinical Laserthermia Systems AB meddelar slutförandet av riktad emission

Clinical Laserthermia Systems
Regulatory press release2026-09-07 14:30

CLS: Clinical Laserthermia Systems AB announces completion of directed issue

Clinical Laserthermia Systems
Regulatory press release2026-09-03 20:30

CLS: Clinical Laserthermia Systems AB resolves on a directed issue

Clinical Laserthermia Systems
Regulatory press release2026-09-03 20:30

CLS: Clinical Laserthermia Systems AB beslutar om riktad emission

Clinical Laserthermia Systems
Regulatory press release2026-08-31 16:45

CLS: Clinical Laserthermia Systems AB announces completion of rights issue of units

Clinical Laserthermia Systems
Regulatory press release2026-08-31 16:45

CLS: Clinical Laserthermia Systems AB meddelar slutförandet av företrädesemissionen av units

Clinical Laserthermia Systems
Regulatory press release2026-08-31 08:30

CLS: Clinical Laserthermia Systems utser Katarina Lundqvist till permanent CFO

Clinical Laserthermia Systems
Regulatory press release2026-08-31 08:30

CLS: Clinical Laserthermia Systems appoints Katarina Lundqvist as permanent CFO

Clinical Laserthermia Systems
Press release2026-08-24 12:10

Redeye: CLS: Rights issue outcome

Clinical Laserthermia Systems
Regulatory press release2026-08-20 21:25

CLS: Clinical Laserthermia Systems AB tillkännager utfall i företrädesemission av units

Clinical Laserthermia Systems